Skip to main content
Have a personal or library account? Click to login
Risk Factor Clusters and Cardiovascular Disease in High-Risk Patients: The UCC-SMART Study Cover

Risk Factor Clusters and Cardiovascular Disease in High-Risk Patients: The UCC-SMART Study

Open Access
|Dec 2021

References

  1. Damen JA, Hooft L, Schuit E, et al. Prediction models for cardiovascular disease risk in the general population: Systematic review. BMJ. 2016; 353: i2416. DOI: 10.1136/bmj.i2416
  2. Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017; 70(1): 125. DOI: 10.1016/j.jacc.2017.04.052
  3. Berkelmans GFN, van der Graaf Y, Dorresteijn JAN, et al. Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosis. Int J Cardiol. 2018; 251: 96102. DOI: 10.1016/j.ijcard.2017.07.026
  4. Bowry AD, Lewey J, Dugani SB, Choudhry NK. The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management. Can J Cardiol. 2015; 31(9): 11519. DOI: 10.1016/j.cjca.2015.06.028
  5. Huxley RR, Hirakawa Y, Hussain MA, et al. Age- and Sex-Specific Burden of Cardiovascular Disease Attributable to 5 Major and Modifiable Risk Factors in 10 Asian Countries of the Western Pacific Region. Circ J. 2015; 79(8): 166274. DOI: 10.1253/circj.CJ-15-0661
  6. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004; 364(9438): 93752. DOI: 10.1016/S0140-6736(04)17018-9
  7. Yusuf HR, Giles WH, Croft JB, Anda RF, Casper ML. Impact of multiple risk factor profiles on determining cardiovascular disease risk. Preventive medicine. 1998; 27(1): 19. DOI: 10.1006/pmed.1997.0268
  8. Wang X, Dalmeijer GW, den Ruijter HM, et al. Clustering of cardiovascular risk factors and carotid intima-media thickness: The USE-IMT study. PLoS One. 2017; 12(3): e0173393. DOI: 10.1371/journal.pone.0173393
  9. Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999; 159(10): 11049. DOI: 10.1001/archinte.159.10.1104
  10. Peters SAE, Wang X, Lam TH, et al. Clustering of risk factors and the risk of incident cardiovascular disease in Asian and Caucasian populations: Results from the Asia Pacific Cohort Studies Collaboration. BMJ open. 2018; 8(3): e019335. DOI: 10.1136/bmjopen-2017-019335
  11. Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005; 112(5): 66673. DOI: 10.1161/CIRCULATIONAHA.104.516948
  12. Glynn LG, Buckley B, Reddan D, et al. Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. The British journal of general practice: The journal of the Royal College of General Practitioners. 2008; 58(552): 48894. DOI: 10.3399/bjgp08X319459
  13. Wassink YvdG AMJ, Olijhoek JK, Visseren FLJ, for the SMART Study Group. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. European Heart Journal. 2008; 29(2): 21323. DOI: 10.1093/eurheartj/ehm582
  14. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: Rationale and design. Eur J Epidemiol. 1999; 15(9): 77381. DOI: 10.1023/A:1007621514757
  15. Sharif S, Visseren FLJ, Spiering W, de Jong PA, Bots ML, Westerink J. Arterial stiffness as a risk factor for cardiovascular events and all-cause mortality in people with Type 2 diabetes. Diabetic medicine: A journal of the British Diabetic Association. 2019; 36(9): 112532. DOI: 10.1111/dme.13954
  16. Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016; 37(39): 29993058. DOI: 10.1093/eurheartj/ehw272
  17. Federatie Medisch Specialisten. Cardiovasculair risicomanagement (CVRM). 2019.
  18. Pigott TD. A Review of Methods for Missing Data. Educational Research and Evaluation. 2001; 7(4): 35383. DOI: 10.1076/edre.7.4.353.8937
  19. Crowson CS, Therneau TM, O’fallon WM. Attributable risk estimation in cohort studies Rochester. Minnesota: Department of Health Sciences Research Mayo Clinic; 2009.
  20. Wang X, Bots ML, Yang F, et al. A comparison of the prevalence and clustering of major cardiovascular risk factors in the Netherlands and China. Eur J Prev Cardiol. 2016; 23(16): 176673. DOI: 10.1177/2047487316648474
  21. Gao B, Zhang L, Wang H, China National Survey of Chronic Kidney Disease Working G. Clustering of Major Cardiovascular Risk Factors and the Association with Unhealthy Lifestyles in the Chinese Adult Population. PLoS One. 2013; 8(6): e66780. DOI: 10.1371/journal.pone.0066780
  22. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute cardiovascular risk. Lancet. 2005; 365(9457): 43441. DOI: 10.1016/S0140-6736(05)70240-3
  23. Hong X, Qing Y, Jing H, Wang Z, Yang H, Shengxiang Q, Chen X, Wang C, Zhou H, Li C, Qin Z, Xu F. Prevalence and clustering of cardiovascular risk factors: A cross-sectional survey among Nanjing adults in China. BMJ open. 2018. DOI: 10.1136/bmjopen-2017-020530
  24. Kaasenbrood L, Boekholdt SM, van der Graaf Y, et al. Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population. Circulation. 2016; 134(19): 141929. DOI: 10.1161/CIRCULATIONAHA.116.021314
  25. Tan CE, Glantz SA. Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: A meta-analysis. Circulation. 2012; 126(18): 217783. DOI: 10.1161/CIRCULATIONAHA.112.121301
  26. Forouzanfar MH, Liu P, Roth GA, et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990–2015. Jama. 2017; 317(2): 16582. DOI: 10.1001/jama.2016.19043
  27. Bernabe-Ortiz A, Sal y Rosas VG, Ponce-Lucero V, et al. Effect of salt substitution on community-wide blood pressure and hypertension incidence. Nature Medicine. 2020; 26(3): 3748. DOI: 10.1038/s41591-020-0754-2
DOI: https://doi.org/10.5334/gh.897 | Journal eISSN: 2211-8179
Language: English
Submitted on: Aug 7, 2020
Accepted on: Nov 11, 2021
Published on: Dec 21, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Emily I. Holthuis, Frank L. J. Visseren, Michiel L. Bots, Sanne A. E. Peters, on behalf of the UCC-SMART study group, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.